Genomenon Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 136

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $6.03M

  • Investors
  • 26

Genomenon General Information

Description

Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software offers a set of diagnostic and discovery tools to identify disease-causing genomic variants and assists in treating cancer and other heritable diseases, enabling physicians to improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 206 East Huron Street
  • Suite 114
  • Ann Arbor, MI 48104
  • United States
+1 (734)
Primary Industry
Decision/Risk Analysis
Other Industries
Business/Productivity Software
Discovery Tools (Healthcare)
Automation/Workflow Software
Corporate Office
  • 206 East Huron Street
  • Suite 114
  • Ann Arbor, MI 48104
  • United States
+1 (734)

Genomenon Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomenon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC (Series B2) 30-Jul-2026 $6.03M Completed Generating Revenue
15. Later Stage VC (Series B1) 16-May-2024 Completed Generating Revenue
14. Later Stage VC (Series B) 25-Feb-2022 Completed Generating Revenue
13. Grant 15-Feb-2022 Completed Generating Revenue
12. Secondary Transaction - Private 01-Aug-2021 Completed Generating Revenue
11. Later Stage VC (Series A) 16-Mar-2021 Completed Generating Revenue
10. Debt - PPP 07-Apr-2020 Completed Generating Revenue
9. Grant 01-May-2019 Completed Generating Revenue
8. Seed Round 08-Jan-2019 $2.5M $6M Completed Generating Revenue
7. Seed Round 07-Jul-2018 $1.25M $3.5M Completed Generating Revenue
To view Genomenon’s complete valuation and funding history, request access »

Genomenon Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series B
Series A
Seed 1 1,303,131 $0.000100 $1.9 $1.9 1x $1.9 7.83%
Seed 1,590,190 $0.000100 $1.71 $1.71 1x $1.71 9.56%
To view Genomenon’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genomenon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software o
Decision/Risk Analysis
Ann Arbor, MI
136 As of 2026

Waltham, MA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genomenon Competitors (22)

One of Genomenon’s 22 competitors is Scipher Medicine, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Scipher Medicine Venture Capital-Backed Waltham, MA
Congenica Formerly VC-backed Cambridge, United Kingdom
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
PierianDx Private Equity-Backed Creve Coeur, MO
Foundation Medicine Formerly VC-backed Boston, MA
You’re viewing 5 of 22 competitors. Get the full list »

Genomenon Patents

Genomenon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4133109-A1 Systems and methods for gene variant grouping and visualization Pending 10-Apr-2020
EP-4133109-A4 Systems and methods for gene variant grouping and visualization Pending 10-Apr-2020
US-12712087-B2 Systems and methods for gene variant grouping and visualization Active 10-Apr-2020
US-20230298769-A1 Systems and methods for gene variant grouping and visualization Active 10-Apr-2020 G16B50/10

Genomenon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomenon Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sorin Capital Funds Venture Capital Minority
Beringea Venture Capital Minority
P93 Ventures Venture Capital Minority
Spring Mountain Capital Growth/Expansion Minority
The 4100 Group Venture Capital Minority
You’re viewing 5 of 26 investors. Get the full list »

Genomenon Acquisitions (1)

Genomenon’s most recent deal was a Merger/Acquisition with Boston Genetics. The deal was made on 27-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Boston Genetics 27-Jun-2023 Merger/Acquisition BPO/Outsource Services
To view Genomenon’s complete acquisitions history, request access »

Genomenon FAQs

  • When was Genomenon founded?

    Genomenon was founded in 2014.

  • Where is Genomenon headquartered?

    Genomenon is headquartered in Ann Arbor, MI.

  • What is the size of Genomenon?

    Genomenon has 136 total employees.

  • What industry is Genomenon in?

    Genomenon’s primary industry is Decision/Risk Analysis.

  • Is Genomenon a private or public company?

    Genomenon is a Private company.

  • What is the current valuation of Genomenon?

    The current valuation of Genomenon is .

  • What is Genomenon’s current revenue?

    The current revenue for Genomenon is .

  • How much funding has Genomenon raised over time?

    Genomenon has raised $42.8M.

  • Who are Genomenon’s investors?

    Sorin Capital Funds, Beringea, P93 Ventures, Spring Mountain Capital, and The 4100 Group are 5 of 26 investors who have invested in Genomenon.

  • Who are Genomenon’s competitors?

    Scipher Medicine, Congenica, Personal Genome Diagnostics, PierianDx, and Foundation Medicine are some of the 22 competitors of Genomenon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process